Eastern Health, Canada   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: St. John's Canada (2005)

Organization Overview

First Clinical Trial
2007
NCT00528008
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Andrea L Woodland | ANZUP and Eastern Health Box Hill Hospital | Eastern Health | Eastern Health, Canada | Eastern Health, Victoria

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Communicable Diseases (Phase 3)

Coronavirus Infections (Phase 3)

Embolism (Phase 4)

Infections (Phase 3)

Kidney Diseases (Phase 4)

Multiple Pulmonary Nodules (Phase 3)

Multiple Sclerosis (Phase 3)

Neoplasms (Phase 3)

Prostatic Neoplasms (Phase 3)

Pulmonary Embolism (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Sclerosis (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Solitary Pulmonary Nodule (Phase 3)

Thrombosis (Phase 4)

Tremor (Phase 3)

Venous Thrombosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 15